Published in J Clin Microbiol on May 01, 1988
Interaction of chlamydiae and host cells in vitro. Microbiol Rev (1991) 8.10
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Diagnostic value of the polymerase chain reaction for Chlamydia detection as determined in a follow-up study. J Clin Microbiol (1991) 3.27
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol (1992) 3.10
Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol (1990) 2.36
Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract. J Clin Microbiol (1992) 1.70
Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob Agents Chemother (1994) 1.49
Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun (2000) 1.34
Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene. J Clin Microbiol (1994) 1.22
Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR. J Clin Microbiol (1994) 1.17
Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay. J Clin Microbiol (1998) 1.09
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun (2001) 1.08
Factors influencing the infectivity of Chlamydia pneumoniae elementary bodies on HL cells. J Clin Microbiol (1992) 0.97
Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations. J Clin Microbiol (1999) 0.92
Growth in serum-free medium improves isolation of Chlamydia pneumoniae. J Clin Microbiol (1993) 0.89
Transport and storage conditions for cultural recovery of Chlamydia pneumoniae. J Clin Microbiol (1995) 0.88
Lack of effective anti-apoptotic activities restricts growth of Parachlamydiaceae in insect cells. PLoS One (2012) 0.87
Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1). J Clin Microbiol (2002) 0.85
Biological enrichment of Mycoplasma agents by cocultivation with permissive cell cultures. Appl Environ Microbiol (2008) 0.79
Chlamydia pneumoniae infection in polarized epithelial cell lines. Infect Immun (2010) 0.78
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
ISOLATION OF THE TRACHOMA AGENT IN CELL CULTURE. Proc Soc Exp Biol Med (1965) 7.38
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
Effect of swab type and storage temperature on the isolation of Chlamydia trachomatis from clinical specimens. J Clin Microbiol (1985) 3.29
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Factors affecting the sensitivity of replicating McCoy cells in the isolation and growth of chlamydia A (TRIC agents). J Hyg (Lond) (1976) 2.76
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J Clin Microbiol (1984) 1.87
Survival of Chlamydia trachomatis in different transport media and at different temperatures: diagnostic implications. Br J Vener Dis (1984) 1.59
Improved method for isolation and growth of Chlamydia trachomatis in McCoy cells treated with cycloheximide using polyethylene glycol. J Clin Pathol (1985) 0.98
Effect of polybrene on isolation of Chlamydia trachomatis from clinical specimens. J Clin Microbiol (1985) 0.88
Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol (1970) 10.68
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis (1974) 6.18
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis (1993) 4.02
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol (1967) 3.63
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture. Antimicrob Agents Chemother (1977) 3.34
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol (1973) 2.96
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 2.74
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis (1985) 2.60
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49
Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
Differentiation of TRIC and LGV organisms based on enhancement of infectivity by DEAE-dextran in cell culture. J Infect Dis (1972) 2.36
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb (1993) 2.27
Three new serovars of Chlamydia trachomatis: Da, Ia, and L2a. J Infect Dis (1991) 2.26
TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol (1974) 2.22
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A (1995) 2.15
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis (1988) 2.15
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis (1997) 2.06
In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob Agents Chemother (1988) 1.99
Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test. J Clin Microbiol (1979) 1.96
Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis (1999) 1.91
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis (1998) 1.89
A potency test for trachoma vaccine utilizing the mouse toxicity prevention test. Am J Ophthalmol (1967) 1.89
Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections. Am J Med (1990) 1.86
Serological response to Chlamydia pneumoniae infection. J Clin Microbiol (1990) 1.86
Characterization of the group antigen of Chlamydia trachomatis. Infect Immun (1971) 1.86
Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb (1991) 1.86
Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis (1997) 1.82
Chlamydia trachomatis immunotype J. J Immunol (1975) 1.73
Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis (1991) 1.69
An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis (1993) 1.63
Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol (1993) 1.63
Pneumococcal isolations from patients with pneumonia and control subjects in a prepaid medical care group. Am Rev Respir Dis (1975) 1.60
Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight-year period. Am J Epidemiol (1973) 1.55
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis (1999) 1.54
Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events. Circulation (1998) 1.53
Structural and antigenic analysis of Chlamydia pneumoniae. Infect Immun (1990) 1.52
Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. N Engl J Med (1966) 1.52
Isolation of cytomegalovirus from a cohort of 100 infants throughout the first year of life. Proc Soc Exp Biol Med (1969) 1.50
Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med (1993) 1.44
Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am J Ophthalmol (1967) 1.43
Direct fluorescent monoclonal antibody stain for rapid detection of infant Chlamydia trachomatis infections. Pediatrics (1984) 1.43
Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines. Am J Dis Child (1969) 1.43
Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol (1990) 1.42
Past use of an intrauterine device and risk of tubal pregnancy. Epidemiology (1993) 1.41
Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am J Ophthalmol (1967) 1.41
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis (1992) 1.39
Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J Infect Dis (1995) 1.37
Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol (1993) 1.37
Pathogenesis and immunology of trachoma. Trans Assoc Am Physicians (1972) 1.37
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis (2000) 1.36
Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis (1995) 1.36
Centers for Disease Control guidelines for prevention and control of Chlamydia trachomatis infections. Summary and Commentary. Ann Intern Med (1986) 1.31
A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun (1993) 1.29
Isolation of TRIC agents and mycoplasma from the genito-urinary tracts of patients of a venereal disease clinic. Am J Ophthalmol (1967) 1.28
Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study. Stroke (2000) 1.26
Further characterization of Chlamydia pneumoniae specific monoclonal antibodies. Microbiol Immunol (1995) 1.26
Isolation of Mycoplasma hominis, T-strains, and cytomegalovirus from the cervix of pregnant women. Am J Obstet Gynecol (1970) 1.26
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol (1997) 1.24
Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study. Circulation (2000) 1.22
Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children. J Infect Dis (1988) 1.20
Ultrastructural study of entry of Chlamydia strain TWAR into HeLa cells. Infect Immun (1988) 1.18
Isolation of a gene encoding a Chlamydia sp. strain TWAR protein that is recognized during infection of humans. Infect Immun (1989) 1.18
Mycoplasma pneumoniae in the community. Am J Epidemiol (1971) 1.17
Sensitivity and resistance of TRIC agents to penicillin, tetracycline and sulfa drugs. Am J Ophthalmol (1967) 1.17
Antibiotic treatment trials for secondary prevention of coronary artery disease events. Circulation (1999) 1.17
Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization. JAMA (1971) 1.16
Chlamydia trachomatis infection in Fitz-Hugh-Curtis syndrome. Am J Obstet Gynecol (1980) 1.16
Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation (1998) 1.15
Transmission of Chlamydia pneumoniae in young children in a Japanese family. J Infect Dis (1990) 1.15
Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. Am J Ophthalmol (1967) 1.14
Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis (2000) 1.13
Epidemiology of viral and mycoplasmal agents associated with childhood lower respiratory illness in a civilian population. J Pediatr (1971) 1.13
Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. Antimicrob Agents Chemother (1995) 1.12
Culture-negative endocarditis probably due to Chlamydia pneumoniae. J Infect Dis (1990) 1.11
Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1991) 1.09